Announcements

14 December 2021
Oxygen Has Established Companionship with Its Sister Journal Antioxidants


We are pleased to announce that the new journal Oxygen (ISSN 2673-9801) has established companionship with its sister journal Antioxidants (ISSN 2076-3921).

Oxygen is an international, peer-reviewed, open access journal that publishes original research in the areas of chemistry, biology, and biomedicine that all relate to oxygen. The aim is to provide a platform for research and findings regarding oxygen studies and related topics, including chemical properties of oxygen and reactions in which it is involved, the role of oxygen in biological systems, reactive oxygen species, antioxidants and redox reactions, etc.

Oxygen publishes regular research articles, reviews, and short notes. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of the papers. For theory papers, full details of proofs must be provided so that results can be checked. For experimental papers, full experimental details must be provided so that results can be reproduced. Additionally, electronic files or software regarding the full details of the calculations, experimental procedure, etc., can be deposited along with the publication as “Supplementary Material”.

For details on the background and scope of this journal, please click on this link: https://www.mdpi.com/journal/oxygen/about.

Manuscripts are peer-reviewed, and a first decision is provided to authors approximately 15 days after submission; acceptance to publication is undertaken in 3 days (median values for MDPI journals in the second half of 2020). If accepted after peer review, your paper will be published in open access format.

Manuscripts can be submitted via the journal’s online submission system at: https://susy.mdpi.com/user/manuscripts/upload?journal=oxygen.

We cordially invite you to consider Oxygen as the platform for publishing your work.

Oxygen Editorial Office

More News...
Back to TopTop